Edition:
United Kingdom

Sarepta Therapeutics Inc (SRPT.OQ)

SRPT.OQ on NASDAQ Stock Exchange Global Select Market

53.04USD
12 Dec 2017
Change (% chg)

$-1.22 (-2.25%)
Prev Close
$54.26
Open
$54.97
Day's High
$55.05
Day's Low
$52.50
Volume
505,413
Avg. Vol
579,159
52-wk High
$57.50
52-wk Low
$26.26

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 35.01 -1.147
Mar '17 16.34 1.501
FY 2016 Dec '16 5.42 -1.618
Sep '16 0.00 -1.176
Jun '16 0.00 -1.350
Mar '16 0.00 -1.308
FY 2015 Dec '15 1.25 -1.441
Sep '15 0.00 -1.250
Jun '15 0.00 -1.012
Mar '15 0.00 -1.490
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 15 55.83 62.00 39.30 64.62
Quarter Ending Mar-18 9 64.84 72.00 59.41 --
Year Ending Dec-17 16 154.03 159.30 147.90 211.32
Year Ending Dec-18 16 312.30 368.50 267.00 341.81
Earnings (per share)
Quarter Ending Dec-17 13 -0.32 -0.10 -0.56 -0.28
Quarter Ending Mar-18 10 -0.27 -0.11 -0.43 --
Year Ending Dec-17 12 -0.73 -0.20 -0.96 -1.45
Year Ending Dec-18 15 -0.57 0.62 -1.74 -0.29
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.65 32.93
P/E High - Last 5 Yrs. -- 290.75 45.62
P/E Low - Last 5 Yrs. -- 93.66 24.34
Beta 1.28 0.85 0.88
Price to Sales (TTM) 57.46 100.67 5.40
Price to Book (MRQ) 7.43 13.50 5.38
Price to Tangible Book (MRQ) 8.82 13.43 6.78
Price to Cash Flow (TTM) -- 76.23 23.45
% Owned Institutions 68.47 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 433.84 9.00
Sales (TTM) vs TTM 1 Yr. Ago 4,431.04 75.03 5.38
Sales - 5 Yr. Growth Rate -35.07 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 15.04 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago 54.39 -- --
EPS - 5 Yr. Growth Rate -- 43.17 10.79
Capital Spending - 5 Yr. Growth Rate 24.40 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 5.29 1.68 2.18
Current Ratio (MRQ) 5.92 5.36 2.98
LT Debt to Equity (MRQ) 0.00 18.92 11.56
Total Debt to Equity (MRQ) 2.97 20.59 15.81
Interest Coverage (TTM) -353.14 -112.49 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 98.39 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -420.13 -- --
EBITD - 5 Yr. Avg -1,062.58 -261.11 15.24
Operating Margin (TTM) -435.96 -556.64 7.76
Operating Margin - 5 Yr. Avg. -1,089.59 -279.29 10.75
Pre-Tax Margin (TTM) -215.34 -529.88 8.57
Pre-Tax Margin - 5 Yr. Avg. -1,259.74 -279.02 11.17
Net Profit Margin (TTM) -218.67 -531.33 4.88
Net Profit Margin - 5 Yr. Avg. -1,259.74 -282.20 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 288,193 25,314,503 864,673,366
Net Income/Employee (TTM) -630,203 3,332,048 101,717,513
Receivable Turnover (TTM) 5.22 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.17 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -37.95 -0.78 11.00
Return on Assets - 5 Yr. Avg. -65.64 -0.26 12.43
Return on Investment (TTM) -47.63 2.35 14.46
Return on Investment - 5 Yr. Avg. -82.14 2.98 16.28
Return on Equity (TTM) -49.74 2.95 16.05
Return on Equity - 5 Yr. Avg. -86.26 6.40 17.51
  1 Year 3 Year 5 Year
Sales % 332.64 -27.49 -35.07
EPS (TTM) % -5.49 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Sarepta Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 17.90 13.84 82 53
13 Week 47.58 40.40 90 61
26 Week 76.51 63.09 91 69
52 Week -17.87 -30.38 37 46
YTD 84.87 62.35 85 50
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 85.60%
# of Holders: 309
Total Shares Held: 55,324,201
3 Mo. Net Change: 11,344,373
# New Positions: 73
# Closed Positions: 28
# Increased Positions: 203
# Reduced Positions: 72
# Net Buyers: 131
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.